Prognosis
Vaccine Makers Plan Public Stance to Counter Pressure on FDA
- Companies involved include Pfizer, Moderna, Sanofi and others
- Trump has said he expects vaccine ready ahead of election day
This article is for subscribers only.
We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
Drugmakers are planning a public pledge to not send any Covid-19 vaccine to the FDA for review without extensive safety and efficacy data, according to people familiar with the effort.